Use Of Ad26. ZEBOV As Booster Dose A Safe, Immunogenic Vaccine Regimen For Ebola Virus Disease In Children, Trial Shows
December 06, 2022
Infectious Disease Advisor (12/5, Barowski, RN) reports, “The use of the adenovirus type 26 vector-based vaccine encoding the Ebola virus glycoprotein of the Mayinga variant (Ad26. ZEBOV) as a booster for children who previously received 2 doses of the Ad...